Your browser is no longer supported. Please, upgrade your browser.
IQV [NYSE]
IQVIA Holdings Inc.
IndexS&P 500 P/E79.44 EPS (ttm)3.11 Insider Own0.40% Shs Outstand191.50M Perf Week0.00%
Market Cap47.58B Forward P/E24.72 EPS next Y10.00 Insider Trans0.00% Shs Float189.67M Perf Month0.06%
Income607.00M PEG4.10 EPS next Q2.12 Inst Own91.00% Short Float1.39% Perf Quarter5.70%
Sales12.93B P/S3.68 EPS this Y49.50% Inst Trans0.45% Short Ratio2.61 Perf Half Y37.05%
Book/sh31.09 P/B7.95 EPS next Y13.53% ROA1.20% Target Price258.89 Perf Year56.13%
Cash/sh12.49 P/C19.81 EPS next 5Y19.39% ROE4.80% 52W Range146.00 - 254.05 Perf YTD38.03%
Dividend- P/FCF35.43 EPS past 5Y-14.20% ROI3.50% 52W High-1.92% Beta1.42
Dividend %- Quick Ratio1.10 Sales past 5Y14.60% Gross Margin33.60% 52W Low70.67% ATR4.69
Employees72000 Current Ratio1.10 Sales Q/Q23.80% Oper. Margin5.60% RSI (14)54.99 Volatility1.89% 1.81%
OptionableYes Debt/Eq2.06 EPS Q/Q159.60% Profit Margin2.20% Rel Volume0.69 Prev Close247.30
ShortableYes LT Debt/Eq2.03 EarningsJul 27 BMO Payout0.00% Avg Volume1.01M Price249.18
Recom1.70 SMA200.71% SMA502.24% SMA20022.77% Volume233,396 Change0.76%
Apr-16-21Upgrade Stephens Equal-Weight → Overweight $180 → $250
Mar-08-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight $218
Mar-03-21Initiated Barclays Overweight $220
Jul-07-20Initiated Stephens Equal-Weight $150
Mar-02-20Initiated Deutsche Bank Buy $190
Jan-08-20Initiated Wells Fargo Overweight $180
Jan-07-20Initiated Citigroup Buy $185
Dec-13-19Upgrade CFRA Sell → Hold
Nov-14-19Upgrade Wolfe Research Peer Perform → Outperform
Jun-21-19Upgrade Mizuho Neutral → Buy $150 → $175
May-28-19Initiated SVB Leerink Outperform
Jan-18-19Upgrade Jefferies Hold → Buy
Oct-09-18Initiated UBS Buy
Oct-02-18Reiterated Robert W. Baird Outperform $143 → $146
Jul-25-18Upgrade BofA/Merrill Neutral → Buy
Jul-25-18Reiterated Stifel Buy $128 → $150
Jul-03-18Upgrade Raymond James Outperform → Strong Buy
Apr-13-18Upgrade Goldman Neutral → Buy
Mar-07-18Upgrade SunTrust Hold → Buy
Jan-19-18Initiated Evercore ISI Outperform $112
Aug-02-21 04:19AM  
Jul-27-21 02:31PM  
01:01PM  
08:25AM  
07:00AM  
Jul-23-21 09:57AM  
Jul-22-21 08:00PM  
08:00AM  
07:30AM  
Jul-21-21 09:26AM  
Jul-20-21 03:01PM  
Jul-13-21 04:15PM  
Jul-07-21 10:40AM  
Jul-03-21 05:03AM  
Jul-02-21 09:02AM  
Jun-25-21 10:52AM  
Jun-24-21 04:15PM  
Jun-15-21 08:00AM  
06:58AM  
Jun-14-21 08:00AM  
Jun-08-21 10:25AM  
08:00AM  
Jun-03-21 04:30PM  
May-28-21 04:22AM  
May-24-21 04:36PM  
07:56AM  
May-22-21 08:00AM  
May-21-21 07:00AM  
May-20-21 04:15PM  
12:45PM  
May-19-21 08:00AM  
May-18-21 02:40PM  
11:32AM  
May-17-21 04:22PM  
May-11-21 09:03AM  
May-10-21 08:00AM  
May-03-21 12:45PM  
08:00AM  
Apr-29-21 08:00AM  
06:00AM  
Apr-28-21 08:00AM  
Apr-23-21 09:15AM  
03:36AM  
Apr-22-21 03:30PM  
10:28AM  
10:19AM  
08:25AM  
07:00AM  
Apr-20-21 08:33AM  
Apr-07-21 02:23PM  
Apr-06-21 01:00PM  
09:15AM  
07:30AM  
Apr-05-21 09:49AM  
09:46AM  
Apr-01-21 07:03AM  
07:00AM  
Mar-31-21 12:22PM  
Mar-20-21 12:34PM  
Mar-18-21 04:48AM  
Mar-16-21 09:38AM  
Mar-12-21 11:30AM  
Mar-09-21 08:00AM  
Mar-08-21 08:00AM  
Mar-03-21 10:02AM  
Mar-02-21 04:15PM  
Feb-17-21 04:27PM  
Feb-16-21 07:30AM  
03:41AM  
03:26AM  
12:35AM  
Feb-11-21 09:00AM  
08:00AM  
Feb-10-21 01:30PM  
10:27AM  
08:35AM  
07:23AM  
07:00AM  
Feb-09-21 09:29AM  
Feb-08-21 10:39AM  
Feb-05-21 05:04PM  
Feb-04-21 08:00AM  
Feb-03-21 12:31PM  
Feb-01-21 08:00AM  
Jan-26-21 04:15PM  
Jan-11-21 01:23AM  
Jan-05-21 08:00AM  
Dec-21-20 07:30AM  
Dec-17-20 08:00AM  
Dec-16-20 08:00AM  
Dec-09-20 10:10AM  
Dec-08-20 12:54PM  
Dec-07-20 08:00AM  
Dec-06-20 03:14AM  
Nov-19-20 11:30AM  
Nov-10-20 09:43AM  
Nov-05-20 09:35AM  
09:32AM  
Nov-02-20 08:00AM  
Oct-23-20 09:35AM  
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANHAKL JOHN GDirectorDec 23Buy176.9563,45111,227,654137,410Dec 28 05:07 PM
Rittenmeyer Ronald ADirectorNov 24Sale172.969,5901,658,68611,894Nov 25 05:03 PM
Rittenmeyer Ronald ADirectorNov 16Sale174.3540,7927,112,08521,484Nov 18 05:03 PM
BOUSBIB ARISee RemarksOct 12Sale170.0069,12011,750,400652,035Oct 14 05:05 PM
BOUSBIB ARISee RemarksSep 15Sale164.3646,0807,573,709652,035Sep 17 05:06 PM
BOUSBIB ARISee RemarksAug 14Sale161.6669,12011,173,939652,035Aug 18 05:03 PM
STAUB W RICHARDSee RemarksAug 07Option Exercise87.2033,8902,955,12732,877Aug 11 05:02 PM
STAUB W RICHARDSee RemarksAug 07Sale160.3220,3673,265,33212,470Aug 11 05:02 PM
Bruehlman Ronald ESee RemarksAug 04Buy159.9410,0001,599,40026,751Aug 05 05:02 PM